236 related articles for article (PubMed ID: 34389380)
41. The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
Chiou WC; Chen JC; Chen YT; Yang JM; Hwang LH; Lyu YS; Yang HY; Huang C
Biochem Biophys Res Commun; 2022 Feb; 591():130-136. PubMed ID: 33454058
[TBL] [Abstract][Full Text] [Related]
42. Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea compounds in vitro.
Ngwe Tun MM; Luvai E; Nwe KM; Toume K; Mizukami S; Hirayama K; Komatsu K; Morita K
Arch Virol; 2022 Jul; 167(7):1547-1557. PubMed ID: 35606466
[TBL] [Abstract][Full Text] [Related]
43. Inhibitory effect of the green tea molecule EGCG against dengue virus infection.
Raekiansyah M; Buerano CC; Luz MAD; Morita K
Arch Virol; 2018 Jun; 163(6):1649-1655. PubMed ID: 29429035
[TBL] [Abstract][Full Text] [Related]
44. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.
Seyedpour S; Khodaei B; Loghman AH; Seyedpour N; Kisomi MF; Balibegloo M; Nezamabadi SS; Gholami B; Saghazadeh A; Rezaei N
J Cell Physiol; 2021 Apr; 236(4):2364-2392. PubMed ID: 32901936
[TBL] [Abstract][Full Text] [Related]
45.
Pandey AK; Verma S
Drug Dev Ind Pharm; 2022 Oct; 48(10):539-551. PubMed ID: 36250723
[TBL] [Abstract][Full Text] [Related]
46. A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein.
Littler DR; Liu M; McAuley JL; Lowery SA; Illing PT; Gully BS; Purcell AW; Chandrashekaran IR; Perlman S; Purcell DFJ; Quinn RJ; Rossjohn J
J Biol Chem; 2021 Dec; 297(6):101362. PubMed ID: 34756886
[TBL] [Abstract][Full Text] [Related]
47. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
[TBL] [Abstract][Full Text] [Related]
48. Epigallocatechin Gallate Inhibits the Uridylate-Specific Endoribonuclease Nsp15 and Efficiently Neutralizes the SARS-CoV-2 Strain.
Hong S; Seo SH; Woo SJ; Kwon Y; Song M; Ha NC
J Agric Food Chem; 2021 Jun; 69(21):5948-5954. PubMed ID: 34015930
[TBL] [Abstract][Full Text] [Related]
49. Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study.
Al-Shuhaib MBS; Hashim HO; Al-Shuhaib JMB
Comput Biol Med; 2022 Feb; 141():105155. PubMed ID: 34942397
[TBL] [Abstract][Full Text] [Related]
50. Inactivation of SARS-CoV-2 by Catechins from Green Tea.
Nishimura H; Okamoto M; Dapat I; Katsumi M; Oshitani H
Jpn J Infect Dis; 2021 Sep; 74(5):421-423. PubMed ID: 33518628
[TBL] [Abstract][Full Text] [Related]
51. Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19.
Gangadevi S; Badavath VN; Thakur A; Yin N; De Jonghe S; Acevedo O; Jochmans D; Leyssen P; Wang K; Neyts J; Yujie T; Blum G
J Phys Chem Lett; 2021 Feb; 12(7):1793-1802. PubMed ID: 33577324
[TBL] [Abstract][Full Text] [Related]
52. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.
Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B
J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269
[TBL] [Abstract][Full Text] [Related]
53. Digallate dimers of (-)-epigallocatechin gallate inactivate herpes simplex virus.
Isaacs CE; Xu W; Merz G; Hillier S; Rohan L; Wen GY
Antimicrob Agents Chemother; 2011 Dec; 55(12):5646-53. PubMed ID: 21947401
[TBL] [Abstract][Full Text] [Related]
54. (-)-Epigallocatechin-3-Gallate Inhibits the Life Cycle of Pseudorabies Virus
Huan C; Xu W; Guo T; Pan H; Zou H; Jiang L; Li C; Gao S
Front Cell Infect Microbiol; 2020; 10():616895. PubMed ID: 33520741
[TBL] [Abstract][Full Text] [Related]
55. Entry-inhibitory role of catechins against SARS-CoV-2 and its UK variant.
Mhatre S; Gurav N; Shah M; Patravale V
Comput Biol Med; 2021 Aug; 135():104560. PubMed ID: 34147855
[TBL] [Abstract][Full Text] [Related]
56. The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection.
Weber C; Sliva K; von Rhein C; Kümmerer BM; Schnierle BS
Antiviral Res; 2015 Jan; 113():1-3. PubMed ID: 25446334
[TBL] [Abstract][Full Text] [Related]
57. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.
Morokutti-Kurz M; Fröba M; Graf P; Große M; Grassauer A; Auth J; Schubert U; Prieschl-Grassauer E
PLoS One; 2021; 16(2):e0237480. PubMed ID: 33596218
[TBL] [Abstract][Full Text] [Related]
58. Severe Acute Respiratory Syndrome Coronavirus-2 Inactivation Activity of the Polyphenol-Rich Tea Leaf Extract with Concentrated Theaflavins and Other Virucidal Catechins.
Takeda Y; Tamura K; Jamsransuren D; Matsuda S; Ogawa H
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443390
[TBL] [Abstract][Full Text] [Related]
59. Antiviral Effect of Epigallocatechin Gallate via Impairing Porcine Circovirus Type 2 Attachment to Host Cell Receptor.
Li J; Song D; Wang S; Dai Y; Zhou J; Gu J
Viruses; 2020 Feb; 12(2):. PubMed ID: 32033244
[TBL] [Abstract][Full Text] [Related]
60. Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19.
Cao J; Liu Y; Zhou M; Dong S; Hou Y; Jia X; Lan X; Zhang Y; Guo J; Xiao G; Wang W
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
